Review Article
Effector and Memory CTL Differentiation
- Matthew A. Williams1 andMichael J. Bevan1
- View Affiliations and Author NotesHide Affiliations and Author NotesHoward Hughes Medical Institute and the Department of Immunology, University of Washington, Seattle, Washington 98195; email:[email protected],[email protected]
- Vol. 25:171-192(Volume publication date April 2007)
- First published as a Review in Advance onNovember 27, 2006
- © Annual Reviews
- View CitationHide Citation
Matthew A. Williams, Michael J. Bevan. 2007. Effector and Memory CTL Differentiation.Annual Review Immunology.25:171-192.https://doi.org/10.1146/annurev.immunol.25.022106.141548
Abstract
Technological advances in recent years have allowed for an ever-expanding ability to analyze and quantify in vivo immune responses. MHC tetramers, intracellular cytokine staining, an increasing repertoire of transgenic and “knockout” mice, and the detailed characterization of a variety of infectious models have all facilitated more precise and definitive analyses of the generation and function of cytotoxic T lymphocytes (CTL). Understanding the mechanisms behind the differentiation of effector and memory CTL is of increasing importance to develop vaccination strategies against a variety of established and emerging infectious diseases. This review focuses on recent advances in our understanding of how effector and memory CTL differentiate and survive in vivo in response to viral or bacterial infection.





